China SXT Pharmaceuticals (SXTC) Debt Ratio: 2019-2025

Historic Debt Ratio for China SXT Pharmaceuticals (SXTC) over the last 7 years, with Mar 2025 value amounting to 0.04.

  • China SXT Pharmaceuticals' Debt Ratio fell 98.40% to 0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year increase of 7.98%. This contributed to the annual value of 0.04 for FY2025, which is 39.69% up from last year.
  • As of FY2025, China SXT Pharmaceuticals' Debt Ratio stood at 0.04, which was up 39.69% from 0.03 recorded in FY2024.
  • In the past 5 years, China SXT Pharmaceuticals' Debt Ratio registered a high of 0.35 during FY2021, and its lowest value of 0.00 during FY2022.
  • Moreover, its 3-year median value for Debt Ratio was 0.03 (2024), whereas its average is 0.02.
  • Its Debt Ratio has fluctuated over the past 5 years, first crashed by 99.90% in 2022, then soared by 2,739.84% in 2023.
  • Over the past 5 years, China SXT Pharmaceuticals' Debt Ratio (Yearly) stood at 0.35 in 2021, then crashed by 99.90% to 0.00 in 2022, then skyrocketed by 2,739.84% to 0.01 in 2023, then soared by 173.30% to 0.03 in 2024, then soared by 39.69% to 0.04 in 2025.